Heartland Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2M Buy
6,831
+145
+2% +$47.7K 0.1% 197
2025
Q4
$2.34M Buy
+6,686
New +$2.26M 0.13% 192
2023
Q1
Sell
-3,751
Closed -$1.92M 180
2022
Q4
$1.92M Buy
3,751
+27
+0.7% +$13.7K 0.12% 165
2022
Q3
$1.69M Sell
3,724
-6
-0.2% -$2.87K 0.13% 163
2022
Q2
$1.8M Buy
3,730
+19
+0.5% +$9.4K 0.13% 174
2022
Q1
$1.82M Buy
3,711
+70
+2% +$32K 0.11% 181
2021
Q4
$1.69M Buy
+3,641
New +$1.53M 0.1% 194

Other funds holding ELV

Heartland Advisors's ELV Position: Q1 2026 in Review

Heartland Advisors increased its Elevance Health (ELV) stake by 2.2% in Q1 2026, buying an estimated $47.7K and bringing the position to 6,831 shares worth $2M. The position accounts for 0.1% of the portfolio, ranked #197.

Heartland Advisors first reported a position in ELV in Q4 2021 and has held it in 7 quarters since. The position peaked at $2.34M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Heartland Advisors held 6,831 shares of Elevance Health worth $2M as of Q1 2026.
  • Heartland Advisors bought 145 Elevance Health shares in Q1 2026, an estimated $47.7K.
  • Elevance Health made up 0.1% of Heartland Advisors's portfolio in Q1 2026, its #197 holding.
  • Heartland Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 7 quarters since.
  • Heartland Advisors's Elevance Health position peaked at $2.34M in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Heartland Advisors's 13F filing for Q1 2026, filed 6 May 2026.